Michigan State University (MSU) faculty member Dr. Yasser Aldhamen created a pioneering cancer immunotherapy strategy that can shrink tumors and increase therapeutic resistance against some types of cancer.
This came during a research he recently published in “Molecular Therapy” Journal, which is classified as one of the best scientific journals specialized in genetic and cellular therapy in the world.
Professor Aldhamen’s research project took about two years, completing 41 scientific papers published in prestigious international journals, as well as 3 previous patents registered with the US Food and Drug Administration.
In a statement to the Saudi Press Agency (SPA), Dr. Aldhamen said, “The whole idea is to treat patients without drugs to eliminate cancer.”
“Based on my previous work, a method was devised to harness the naturally active immune system to control tumor growth by activating the action of specific immune system cells, such as NK cells, and innate immune cells, such as macrophages and dendritic cells, within tumors.”
Dr. Aldhamen occupies, in addition to his duties, the position of Deputy Director of Research in the Faculty of Medicine at Michigan State University, and has supervised 5 students in the doctoral stage, two students in the master’s stage, and more than 15 students in the bachelor’s stage.
He also receives some trainees for 8 weeks from the secondary stage, by virtue of his interest in training future researchers in the laboratory, motivating them that making the world takes a long time.
He also participated in 15 conferences around the world, and membership in a number of advisory committees at the university working on developing research and exchanging experiences with researchers in countries such as Egypt and Peru. — SPA
source/content: saudigazette.com.sa (headline edited)
___________
________________
SAUDI ARABIA